Holen Sie sich die Stockscreener-App
24.12
0.42%
0.10
Vorhandelsmarkt:
24.19
0.07
+0.29%
Schlusskurs vom Vortag:
$24.02
Offen:
$24.06
24-Stunden-Volumen:
371.55K
Relative Volume:
0.31
Marktkapitalisierung:
$3.07B
Einnahmen:
$2.89B
Nettoeinkommen (Verlust:
$-33.80M
KGV:
-89.33
EPS:
-0.27
Netto-Cashflow:
$204.10M
1W Leistung:
-1.11%
1M Leistung:
-2.03%
6M Leistung:
-24.44%
1J Leistung:
-19.44%
1-Tages-Spanne:
$23.95
$24.16
1-Wochen-Bereich:
$23.85
$24.60
52-Wochen-Spanne:
$19.50
$33.97
Surgery Partners Inc Stock (SGRY) Company Profile
Firmenname
Surgery Partners Inc
Sektor
Branche
Telefon
615-234-5900
Adresse
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Vergleichen Sie SGRY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
24.12 | 3.07B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
342.34 | 84.29B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.55 | 14.41B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
DVA
Davita Inc
|
152.50 | 13.37B | 12.67B | 827.68M | 1.42B | 9.27 |
|
THC
Tenet Healthcare Corp
|
134.44 | 13.13B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
186.53 | 11.80B | 15.42B | 1.03B | 956.84M | 15.02 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-16 | Eingeleitet | BofA Securities | Buy |
| 2024-10-14 | Eingeleitet | UBS | Buy |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2024-06-28 | Eingeleitet | Macquarie | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2023-11-14 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-06-02 | Hochstufung | BofA Securities | Neutral → Buy |
| 2023-05-12 | Eingeleitet | Mizuho | Buy |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-11-23 | Bestätigt | RBC Capital Mkts | Outperform |
| 2022-06-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-10 | Fortgesetzt | Citigroup | Buy |
| 2021-11-30 | Eingeleitet | Barclays | Overweight |
| 2021-11-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-11-01 | Eingeleitet | JP Morgan | Neutral |
| 2021-10-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-06-23 | Fortgesetzt | Stifel | Hold |
| 2020-09-17 | Bestätigt | The Benchmark Company | Buy |
| 2020-04-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2020-03-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2020-01-14 | Bestätigt | The Benchmark Company | Buy |
| 2018-11-16 | Eingeleitet | UBS | Neutral |
| 2018-09-18 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2018-06-28 | Hochstufung | Stifel | Sell → Hold |
| 2018-01-30 | Bestätigt | The Benchmark Company | Buy |
| 2017-11-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2017-08-09 | Herabstufung | KeyBanc Capital Mkts | Overweight → Sector Weight |
| 2017-08-09 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2017-08-09 | Herabstufung | Stifel | Hold → Sell |
| 2017-04-24 | Bestätigt | Stifel | Hold |
| 2017-03-10 | Herabstufung | Stifel | Buy → Hold |
| 2017-01-31 | Eingeleitet | The Benchmark Company | Buy |
| 2016-06-10 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-03-14 | Bestätigt | RBC Capital Mkts | Outperform |
| 2015-10-27 | Eingeleitet | Stifel | Buy |
| 2015-10-26 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2015-10-26 | Eingeleitet | Raymond James | Strong Buy |
Alle ansehen
Surgery Partners Inc Aktie (SGRY) Neueste Nachrichten
Ambulatory Surgical Centers Market: Transforming Outpatient - openPR
Surgery Partners Inc (SGRY) Stock Price Down 5.48% on Jan 14 - GuruFocus.com
Surgery Partners’ chief strategy officer Marissa Brittenham sells $76,028 in stock - Investing.com India
U.S. Ambulatory Surgery Center Market Set to Witness Significant Growth by 2025-2032: AmSurg Corp., Surgery - EIN News
Surgery Partners (NASDAQ:SGRY) Price Target Lowered to $33.00 at Macquarie - Defense World
(SGRY) Trading Report - Stock Traders Daily
Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating - Marketscreener.com
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts By Investing.com - Investing.com Australia
Surgery Partners, Inc. SEC 10-K Report - TradingView
Surgery Partners, Inc. to Host Earnings Call - ACCESS Newswire
Surgery Partners, Inc. (NASDAQ:SGRY) Q4 2024 Earnings Call Transcript - MSN
Surgery Partners (SGRY) Q4 Earnings and Revenues Surpass Estimates - MSN
Surgery Partners to Acquire National Surgical Healthcare from Irving Place Capital - Bain Capital
Why Surgery Partners’ Stock Is Facing Turbulence - TipRanks
KeyBanc maintains Sector Weight on Surgery Partners stock By Investing.com - Investing.com Australia
Surgery Partners: Strong Growth and Strategic Positioning Drive Buy Rating - TipRanks
Surgery Partners Delays Annual Report Filing - TipRanks
Surgery Partners stock price target cut to $35 by Benchmark - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating - Investing.com India
KeyBanc maintains Sector Weight on Surgery Partners stock - Investing.com India
UBS cuts Surgery Partners stock target to $34, maintains Buy rating By Investing.com - Investing.com South Africa
UBS Cuts Price Target on Surgery Partners to $34 From $38, Keeps Buy Rating -March 04, 2025 at 08:55 am EST - Marketscreener.com
Surgery Partners price target lowered to $35 from $40 at Benchmark - TipRanks
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Re - GuruFocus.com
Surgery Partners Inc (SGRY) Q4 2024 Earnings Call Highlights: Record Revenue and Strategic Expansion - Yahoo Finance
Surgery Partners outlines 2025 guidance with $3.3B-$3.45B revenue target, driven by high acuity growth - MSN
Surgery Partners Reports Strong Revenue Growth for 2024 - TipRanks
Surgery Partners Inc. Reports Record Growth in Earnings Call - TipRanks
Earnings call transcript: Surgery Partners Inc Q4 2024 beats forecasts - Investing.com India
Healthcare Companies Excel In Q1 2024 Earnings Reports - Evrim Ağacı
Surgery Partners Surges on Strong Q4 Results and Bain Capital Pr - GuruFocus.com
Surgery Partners: Q4 Earnings Snapshot - mySA
Surgery Partners Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Surgery Partners Inc (SGRY) Q4 2024 Earnings: Revenue Surpasses Estimates at $864.4 Million, Net Loss Reported - GuruFocus.com
Surgery Partners Surpasses Q4 2024 Revenue Expectations by 4.3%News and Statistics - IndexBox, Inc.
Surgery Partners Inc earnings beat by $0.05, revenue topped estimates - Investing.com Australia
Surgery Partners beats Q4 estimates, shares rise nearly 4% on strong outlook By Investing.com - Investing.com South Africa
Surgery Partners beats Q4 estimates, shares rise nearly 4% on strong outlook - Investing.com Canada
Finanzdaten der Surgery Partners Inc-Aktie (SGRY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):